User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 1 - 25 of 186 results.

Pages

    • Journal article
    Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients.
    Baldin, Paméla[UCL] Van den Eynde, Marc[UCL] Mlecnik, Bernhard Galon, Jérôme (2020) Oncoimmunology — Vol. 9, no.1, p. 1826133 [1-3] (2020)
    • Speech
    Effet de la chimiothérapie systémique sur la maladie gélatineuse du péritoine
    Rahmi, G Boige, V Goere, D Van den Eynde, Marc[UCL] Hernandez, J Dromain, C Tomasic, G Malka, D Elias, D Ducreux, M (2007) Journées Francophones de Pathologie Digestive (JFPD) — (France) Lyon
    • Speech
    Unusual liver masses in two women
    Dano, Hélène[UCL] Théate, Ivan[UCL] Van den Eynde, Marc[UCL] Lambert, Michel[UCL] Rahier, Jacques[UCL] Annet, Laurence[UCL] Sempoux, Christine[UCL] (2012) Belgian Week of Gastroenterology - XXIVth Edition — (Belgium) Ostend
    • Speech
    Radioembolization using Yttrium 90 microspheres for unresectable liver metastases: a single centre experience
    Gokburun, Yeter[UCL] Zech, Francis[UCL] Lhommel, Renaud[UCL] Borbath, Ivan[UCL] Demorcy, Marianne[UCL] Goffette, Pierre[UCL] Van den Eynde, Marc[UCL] (2017) Belgian Week of Gastroenterology - XXIXth edition — (Belgium) Antwerp
    • Speech
    Comparison of pathological response observed on colorectal cancer metastases resected after different preoperative treatments
    Van den Eynde, Marc[UCL] Gizzi, Marco[UCL] Pairet, Géraldine[UCL] Lefevre, P Lannoy, Valérie[UCL] Gigot, Jean-François[UCL] Navez, Benoît[UCL] Canon, Jean-Luc Sempoux, Christine[UCL] Carrasco, Javier (2012) ESMO 2012 Congress — (Austria) Vienna
    • Speech
    599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
    Carrasco, Javier Beniuga, Gabriela[UCL] Mourin, Anne[UCL] Baldin, Paméla[UCL] Sinapi, Isabelle Schroeder, David De Cuyper, Astrid[UCL] Sclafani, Francesco Hendlisz, Alain van Laethem, Jean-Luc Boulanger, Anne-Sophie Van Ooteghem, Geneviève[UCL] Dermine, Alexandre Delmarcelle, Sophie Huyghe, Nicolas[UCL] Bar, Isabelle Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
    • Journal article
    Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
    Ajani, Jaffer El Hajbi, Farid Cunningham, David Alsina, Maria Thuss-Patience, Peter Scagliotti, Giorgio V Van den Eynde, Marc[UCL] Kim, Sung-Bae Kato, Ken Shen, Lin Li, Liyun Ding, Ningning Shi, Jingwen Barnes, Gisoo Van Cutsem, Eric (2024) ESMO open — Vol. 9, no.1, p. 102202 [1-9] (2024)
    • Speech
    PD-1 MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)
    Siena, S. Elez, E. Peeters, M. André, T. Van den Eynde, Marc[UCL] Ng, K. Cercek, A. Fountzilas, C. Sanchez, F. Hubbard, J. Wu, C. Tabernero, J. Kardosh, A. Saeed, A. Strickler, J. Bekaii-Saab, T. Stecher, M. Palanca-Wessels, M. Van Cutsem, E. (2021) ESMO World Congress on Gastrointestinal Cancer 2021 —
    • Journal article
    Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
    Eng, Cathy Kim, Tae Won Bendell, Johanna Argilés, Guillem Tebbutt, Niall C Di Bartolomeo, Maria Falcone, Alfredo Fakih, Marwan Kozloff, Mark Segal, Neil H Sobrero, Alberto Yan, Yibing Chang, Ilsung Uyei, Anne Roberts, Louise Ciardiello, Fortunato Ahn, JB Asselah, J Badarinath, S Baijal, S Begbie, S Berry, S Canon, JL Carbone, RG Cervantes, A Cha, YJ Chang, K Chaudhry, A Chmielowska, E Cho, SH Chu, D Couture, F Cultrera, J Cunningham, D Van Cutsem, E Cuyle, PJ Davies, J Dowden, S Dvorkin, M Ganju, V Garcia, RV Kerr, R Kim, TY King, K Kortmansky, J Kozloff, M Lam, KO Lee, J Lee, AS Lesperance, B Luppi, G Ma, B Maiello, E Mandanas, R Marshall, J Marx, G Mullamitha, S Nechaeva, M Park, JO Pavlakis, N Ponce, CG Potemski, P Raouf, S Reeves, J Segal, N Siena, S Smolin, A Streb, JO Strickland, A Szutowicz-Zielinska, E Tabernero, JM Tan, B Valera, JS Van den Eynde, Marc[UCL] Vergauwe, P Vickers, M Womack, M Wroblewska, M Young, R (2019) The Lancet Oncology — Vol. 20, no.6, p. 849-861 (2019)
    • Speech
    Clinico-pathological characterization of patients with colorectal cancer and restricted immunohistochemistry overexpression of p53
    Van den Bossche, V. Van den Eynde, Marc[UCL] van Maanen, Aline[UCL] Kartheuser, Alex[UCL] Léonard, Daniel[UCL] Remue, Christophe[UCL] Mourin, Anne[UCL] (2016) Belgian Week of Gastroenterology - XXVIIIth edition — (Belgium) Bruxelles
    • Dissertation
    Characterization of the tumour immune microenvironment in metastatic colorectal cancer
    Van den Eynde, Marc[UCL] (2017)
    • Speech
    Single-Incision Laparoscopic Surgery for Locally Advanced Colorectal Cancer: feasibility, perioperative and short-term oncologic outcomes
    Famiglietti, Federico Léonard, Daniel[UCL] Remue, Christophe[UCL] Abbes Orabi, Nora van Maanen, Aline[UCL] Bachmann, Radu[UCL] Danse, Etienne[UCL] Dragean, Cristina[UCL] Humblet, Yves[UCL] Mourin, Anne[UCL] Maddalena, Frederic[UCL] Scalliet, Pierre[UCL] Sempoux, Christine[UCL] Van den Eynde, Marc[UCL] Kartheuser, Alex[UCL] (2015) 10th Scientific and Annual Meeting of the European Society of Coloproctology — (Ireland) Dublin
    • Journal article
    Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors : the end of a story ?
    Delaunoit, T. Van den Eynde, Marc[UCL] Borbath, Ivan[UCL] Pauwels, Stanislas[UCL] Demetter, P. Demolin, G. Pattyn, Pascale[UCL] Peeters, Marie-Rose[UCL] Roeyen, G. Van Cutsem, Emmanuel[UCL] Van Hootegem, Ph. Van Laethem, J. L. Verslype, C.[UCL] Hendlisz, A. (2009) Acta Gastro-Enterologica Belgica (Multilingual Edition) — Vol. 72, no. 1, p. 49-53 (2009)
    • Journal article
    Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
    Bourhis, Jean Stein, Alexander Paul de Boer, Jan Van den Eynde, Marc[UCL] Gold, Kathryn A Stintzing, Sebastian Becker, Jürgen C Moran, Michael Schroeder, Andreas Pennock, Gregory Salmio, Satu Esser, Regina Ciardiello, Fortunato (2021) Cancer treatment reviews — Vol. 97, p. 102172 [1-9] (2021)
    • Speech
    Long term oncological results and quality of life after HIPEC for carcinomatosis of colorectal origin
    Barbois, Sandrine[UCL] Léonard, Daniel[UCL] Souchet, A[UCL] Remue, Christophe[UCL] Abbes Orabi, Nora[UCL] Bachmann, Radu[UCL] Van den Eynde, Marc[UCL] Wittebole, Xavier[UCL] Cotte, E[UCL] Danse, Etienne[UCL] Mourin, Anne[UCL] Dragean, Cristina[UCL] Leclercq, Gisèle[UCL] Kartheuser, Alex[UCL] (2018) Belgian Week of Gastroenterology - XXXth edition — (Belgium) Antwerp
    • Speech
    Comparison of Pathological Responses (PR) Observed on Colorectal Cancer Metastases (CRCM) Resected After Different Preoperative Treatments
    Van den Eynde, Marc[UCL] Gizzi, M. Pairet, G. Lefesvre, P. Lannoy, V. Gigot, J. Navez, Benoît[UCL] Canon, J. Sempoux, C. Carrasco, J. (2012) ESMO Congress 2012 —
    • Journal article
    Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial
    Aparicio, Thomas Bouché, Olivier Etienne, Pierre-Luc Barbier, Emilie Mineur, Laurent Desgrippes, Romain Guérin-Meyer, Véronique Hocine, Fayçal Martin, Jean Le Brun-Ly, Valérie Cretin, Jacques Desramé, Jérôme Rinaldi, Yves Cany, Laurent Falandry, Claire Lefevre, Leila Bengrine Marous, Miguelle Terrebonne, Eric Mosser, Laurent Turpin, Justine Turpin, Anthony Bauguion, Lucille Reichling, Cynthia Van den Eynde, Marc[UCL] Carola, Elisabeth Hiret, Sandrine (2023) Digestive and liver disease — Vol. 55, no. 4, p. 541-548 (2023)
    • Speech
    O16 Immunoscore® Colon analytical performance
    Van den Eynde, Marc[UCL] (2016) 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) — National Harbor, MD, USA.
    • Journal article
    Single-Incision Laparoscopic Surgery for Locally Advanced Colorectal Cancer: feasibility, short-term and oncologic outcomes
    Famiglietti, Federico[UCL] Léonard, Daniel[UCL] Bachmann, Radu[UCL] Remue, Christophe[UCL] Abbes Orabi, Nora[UCL] Van Maanen, Aline[UCL] Van den Eynde, Marc[UCL] Kartheuser, Alex[UCL] (2018) Acta Gastro-Enterologica Belgica — Vol. 81, no. 1, p. 23-28 (2018)
    • Speech
    SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)
    Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphaël Peeters, Marc Holbrechts, Stéphane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand Van Laethem, Jean Luc Ceyssens, Sarah Barbuto, Anna Maria Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Paesmans, Marianne Piccart, Martine Flamen, Patrick (2012) ASCO Annual Meeting — Chicago, Illinois
    • Speech
    Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.
    Hendlisz, Alain Caparica, Rafael Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jozef Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Vermeij, Joanna D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Buggenhout, Alexis Paesmans, Marianne Piccart, Martine Flamen, Patrick (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —
    • Speech
    Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.
    Van den Eynde, Marc[UCL] Huyghe, Nicolas De Cuyper, Astrid[UCL] Sinapi, Isabelle Ferrier, Marie Gilet, Mélanie Van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerome Carrasco, Javier (2021) 2021 Gastrointestinal Cancers Symposium —
    • Speech
    REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).
    Bregni, Giacomo Senti, Chiara Acedo Reina, Elena Gkolfakis, Paraskevas Moretti, Luigi Veron, Ana Demetter, Pieter Liberale, Gabriel Carrasco, Javier Geboes, Karen Paula Gokburun, Yeter Peeters, Marc Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Buyse, Marc E. Deleporte, Amélie Hendlisz, Alain Sclafani, Francesco (2022) 2022 ASCO Gastrointestinal Cancers Symposium —
    • Speech
    Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
    Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2021) 2021 ASCO Annual Meeting I —
    • Journal article
    Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
    Huyghe, Nicolas[UCL] Benidovskaya, Elena[UCL] Beyaert, Simon[UCL] Daumerie, Aurélie[UCL] Maestre Osorio, Finoula[UCL] Aboubakar Nana, Frank[UCL] Bouzin, Caroline[UCL] Van den Eynde, Marc[UCL] (2023) Journal of visualized experiments — Vol. 196, p. e65220 [1-17] (2023)

Pages